THC and CBD are both compounds found in the cannabis plant, but they affect your body in fundamentally different ways. THC is the compound that gets you high. CBD does not. That single distinction drives most of the differences in how they’re used, how they’re regulated, and what side effects they carry. Beyond the psychoactive divide, the two compounds interact with your brain through different mechanisms, treat different conditions, and carry different legal considerations.
Why THC Gets You High and CBD Doesn’t
Both THC and CBD belong to a class of compounds called cannabinoids, and they share the same molecular formula: 21 carbon atoms, 30 hydrogen atoms, and 2 oxygen atoms. The difference is in how those atoms are arranged. THC has a rigid, three-ring structure that lets it fit snugly into a receptor in your brain called CB1. When THC locks into CB1 receptors, it triggers the cascade of effects people associate with being high: euphoria, altered perception of time, increased appetite, and sometimes anxiety or paranoia.
CBD can’t do this. It competes poorly with other compounds for binding at CB1 receptors, which is why it doesn’t produce intoxication. Instead, CBD appears to work as a negative allosteric modulator of CB1. In plain terms, rather than activating the receptor directly, CBD changes the receptor’s shape slightly so that other compounds (including THC and your body’s own cannabinoids) have a harder time activating it. This is one reason CBD can actually dampen some of THC’s effects when the two are used together.
How CBD May Reduce THC’s Side Effects
There’s growing evidence that CBD can soften some of THC’s less pleasant effects. A systematic review of human studies found that CBD may reduce intense experiences of anxiety or psychosis-like effects triggered by THC, though this wasn’t consistent across every study. Survey data and naturalistic studies using hair analysis have also suggested that people who consume cannabis with higher CBD content tend to report fewer memory problems and fewer psychosis-like experiences compared to those using high-THC, low-CBD cannabis.
This interaction is sometimes called the “entourage effect,” and it’s one reason many cannabis products are sold with specific THC-to-CBD ratios. The results are mixed enough that you shouldn’t count on CBD as a reliable antidote to THC-related anxiety, but the pattern is consistent enough to be clinically interesting.
Medical Uses for THC
THC’s primary medical applications center on pain, nausea, and appetite. The FDA has approved synthetic THC (sold as Marinol and Syndros) for treating anorexia and weight loss in AIDS patients. Another synthetic cousin, nabilone (sold as Cesamet), is approved for chemotherapy-induced nausea and vomiting.
Beyond those approved uses, clinical research supports THC’s role in managing several types of chronic pain. Studies in HIV patients who smoked marijuana found self-reported improvements in appetite (97% of users), muscle pain (94%), nausea (93%), and nerve pain (90%). THC has also shown analgesic benefits in fibromyalgia, rheumatoid arthritis, neuropathy, and cancer-related pain. In cancer patients, nabilone provided multi-symptom relief, including pain reduction, compared to patients who didn’t receive it. Cannabis-based extracts have shown benefit across a range of conditions including multiple sclerosis, spinal cord injury, and peripheral nerve injury.
Medical Uses for CBD
CBD’s strongest evidence is in epilepsy. The FDA approved a purified CBD medication (Epidiolex) for seizures associated with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex in patients one year of age and older. In clinical trials, daily CBD treatment over 14 weeks significantly reduced the frequency of convulsive seizures in both Dravet and Lennox-Gastaut patients. An earlier open-label trial found that CBD reduced monthly motor seizures by a median of 36.5% in patients with severe, treatment-resistant childhood-onset epilepsy.
For anxiety, the evidence is promising but less definitive. In one trial, a single 600 mg dose of CBD reduced self-reported anxiety in people with social anxiety disorder during a public speaking test, bringing their anxiety levels down to those of healthy controls. A smaller study of 10 men with generalized anxiety disorder found that CBD reduced anxiety before and after a neuroimaging procedure compared to placebo. Interestingly, anxiety studies have revealed a U-shaped dose-response curve: a moderate dose (300 mg) reduced anxiety in healthy adults before public speaking, while lower (100 mg) and higher (900 mg) doses did not.
Early evidence also suggests potential for CBD in chronic pain and muscle spasticity. In a small study of kidney transplant patients, CBD reduced self-reported pain in six out of seven participants after three weeks. A randomized trial in patients with neurological conditions found that sublingual CBD improved spasticity relative to placebo.
Side Effects
THC’s side effects are largely tied to its psychoactive properties. Short-term use can cause impaired memory and coordination, increased heart rate, dry mouth, red eyes, and in some people, anxiety or paranoia. These effects are dose-dependent and vary widely from person to person.
CBD’s side effects are different in character. The most commonly reported issues are drowsiness, diarrhea, decreased appetite, and irritability. More seriously, CBD can cause liver injury. During the FDA’s review of Epidiolex, liver toxicity emerged as a specific safety concern, particularly at higher doses. CBD also increases the risk of excessive sedation when combined with alcohol or medications that slow brain activity, such as those prescribed for anxiety or sleep disorders. Animal studies have also flagged potential male reproductive toxicity, though this hasn’t been confirmed in humans.
Drug Interactions
Both THC and CBD can interfere with how your body processes other medications. They inhibit certain liver enzymes, particularly one called CYP2C9, that are responsible for breaking down a wide range of common drugs. A comprehensive study of 12 cannabinoids found that nearly all of them inhibited CYP2C9 at concentrations that could realistically occur in the body after normal use. This matters most for medications with a narrow therapeutic index, where small changes in blood levels can cause serious problems. Blood thinners like warfarin are a notable example. If you take prescription medications and are considering CBD or THC products, the potential for interactions is real and worth discussing with a pharmacist.
Legal Status
The legal landscape splits along one key number: 0.3% THC. The 2018 Farm Bill defined hemp as any part of the cannabis plant containing no more than 0.3% delta-9 THC on a dry weight basis and removed hemp from the federal Controlled Substances Act. Cannabis with more than 0.3% THC remains classified as marijuana and is federally illegal, though many states have legalized it for medical or recreational use.
This means CBD products derived from hemp are legal at the federal level, provided they stay under the 0.3% THC threshold. However, state laws vary significantly. Some states have restricted certain hemp-derived THC products even though they technically fall under the federal hemp definition. The FDA has also not approved CBD as a dietary supplement or food additive, which creates a gray area for the countless CBD products sold in stores and online. THC products, whether natural or synthetic, are tightly regulated. The synthetic THC medications approved by the FDA are available only by prescription.